Literature DB >> 19195844

Theory of mind impairment in schizophrenia: meta-analysis.

Emre Bora1, Murat Yucel, Christos Pantelis.   

Abstract

There is now substantial evidence for Theory of mind (ToM) impairment in schizophrenia. Despite this, we know little about how dynamic (state) variables and broad clinical, cognitive and medication characteristics moderate the precise magnitude of the observed ToM deficit during task performance. Meta-analyses were conducted using 36 studies that reported continuous data regarding ToM performances of schizophrenia patients and healthy control subjects. These 36 studies included 1,181 (67% male) patients with schizophrenia and 936 (58.3% male) healthy control subjects. Individual analyses were also conducted for the Hinting and the Eyes tasks. The effects of moderator variables were studied by both subgroup and meta-regression analyses. The effect sizes (Cohen's d) for overall ToM performance and the individual tasks were large (d=0.90-1.08). In "remitted" patients, the degree of ToM impairment was less pronounced than non-remitted patients (d=1.21) but it was still significant (d=0.80). Moreover, the distribution of effect sizes was more homogeneous for the individual tasks, especially in "remitted" patients. General intellectual deficits observed in schizophrenia patients contributed to their ToM impairment only in the remission phase of the illness. While state variables and task specific differences explain a large degree of the heterogeneity of the ToM findings observed in previous studies, the persistence of ToM deficits in "remitted" patients suggests there are trait related mentalising impairments in schizophrenia. Our review also suggests that future research should consider the potential moderating influence of IQ deficits on ToM performance in "remitted" patients, as well as the potential effects of residual symptoms.

Entities:  

Mesh:

Year:  2009        PMID: 19195844     DOI: 10.1016/j.schres.2008.12.020

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  167 in total

1.  Brain mapping biomarkers of socio-emotional processing in schizophrenia.

Authors:  Stephan F Taylor; Angus W MacDonald
Journal:  Schizophr Bull       Date:  2011-09-30       Impact factor: 9.306

Review 2.  Vocational, social, and cognitive rehabilitation for individuals diagnosed with schizophrenia: a review of recent research and trends.

Authors:  Seth Kurzban; Lisa Davis; John S Brekke
Journal:  Curr Psychiatry Rep       Date:  2010-08       Impact factor: 5.285

3.  Social Disconnection in Schizophrenia and the General Community.

Authors:  Michael F Green; William P Horan; Junghee Lee; Amanda McCleery; L Felice Reddy; Jonathan K Wynn
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 9.306

Review 4.  Oxytocin and social cognition in affective and psychotic disorders.

Authors:  M Mercedes Perez-Rodriguez; Katie Mahon; Manuela Russo; Allison K Ungar; Katherine E Burdick
Journal:  Eur Neuropsychopharmacol       Date:  2014-08-01       Impact factor: 4.600

5.  Theory of Mind in patients at clinical high risk for psychosis.

Authors:  Arielle D Stanford; Julie Messinger; Dolores Malaspina; Cheryl M Corcoran
Journal:  Schizophr Res       Date:  2011-07-14       Impact factor: 4.939

6.  Adapting social neuroscience measures for schizophrenia clinical trials, Part 1: ferrying paradigms across perilous waters.

Authors:  Michael F Green; Junghee Lee; Kevin N Ochsner
Journal:  Schizophr Bull       Date:  2013-09-26       Impact factor: 9.306

7.  Gender Differences in Social Cognition: A Cross-Sectional Pilot Study of Recently Diagnosed Patients with Schizophrenia and Healthy Subjects.

Authors:  Guillem Navarra-Ventura; Sol Fernandez-Gonzalo; Marc Turon; Esther Pousa; Diego Palao; Narcis Cardoner; Merce Jodar
Journal:  Can J Psychiatry       Date:  2017-12-07       Impact factor: 4.356

Review 8.  Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome.

Authors:  Matthew J Schreiner; Maria T Lazaro; Maria Jalbrzikowski; Carrie E Bearden
Journal:  Neuropharmacology       Date:  2012-10-23       Impact factor: 5.250

Review 9.  Social impairment in schizophrenia: new approaches for treating a persistent problem.

Authors:  David Dodell-Feder; Laura M Tully; Christine I Hooker
Journal:  Curr Opin Psychiatry       Date:  2015-05       Impact factor: 4.741

10.  Metacognition, Personal Distress, and Performance-Based Empathy in Schizophrenia.

Authors:  Kelsey A Bonfils; Paul H Lysaker; Kyle S Minor; Michelle P Salyers
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.